Aclaris Therapeutics Inc - ACRS - stock price prediction, stock price target, analyst ratings from 8 analysts

Aclaris Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -57.3%, and profit growth estimate of 54.2% for FY25, based on top 8 analyst calls.